CCL2 and triple-A syndrome: The currentevidence suggests that HMGB1 activation of TLR4 amplifies TLR4 signaling, therebypromoting the release of interleukin (IL) 6 and monocyte chemoattractantprotein-1 (MCP-1) from VSMCs and contributing to AAA formation and progression[14].